Exact Mass: 317.12948200000005

Exact Mass Matches: 317.12948200000005

Found 500 metabolites which its exact mass value is equals to given mass value 317.12948200000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lycorenin

(5aR,7S,11bS,11cS)-9,10-dimethoxy-1-methyl-3,5,5a,7,11b,11c-hexahydro-2H-isochromeno[3,4-g]indol-7-ol

C18H23NO4 (317.1626998)


Lycorenine is an alkaloid. Lycorenine is a natural product found in Lycoris radiata, Narcissus munozii-garmendiae, and Hymenocallis littoralis with data available.

   

Triticonazole

Pesticide6_Triticonazole_C17H20ClN3O_(5E)-5-(4-Chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

C17H20ClN3O (317.12948200000005)


   

Piplartine

2(1H)-Pyridinone, 5,6-dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-

C17H19NO5 (317.1263164)


Piplartine is a member of cinnamamides and a dicarboximide. Piperlongumine is a natural product found in Zanthoxylum gilletii, Macropiper, and other organisms with data available. See also: Long Pepper (part of). Piplartine is found in herbs and spices. Piplartine is an alkaloid from the roots of Piper longum (long pepper Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3]. Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3]. Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3].

   

Amaryllisine

Amaryllisine

C18H23NO4 (317.1626998)


An isoquinoline alkaloid that is 3,4,4a,5,6,10b-hexahydro-5,10b-ethanophenanthridin-9-ol bearing three additional methoxy substituents at positions 3, 7 and 8.

   

Haplophyllidine

Haplophyllidine

C18H23NO4 (317.1626998)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

   
   

Hemanthidine

(3S,4aS,11bS,12R)-3-methoxy-4,4a-dihydro-3H,6H-11b,5-ethano[1,3]dioxolo[4,5-j]phenanthridine-6,12-diol

C17H19NO5 (317.1263164)


   
   

9-O-Demethyl-2alpha-hydroxyhomolycorine

9-O-Demethyl-2alpha-hydroxyhomolycorine

C17H19NO5 (317.1263164)


   

LY382884

(3S,4aR,6S,8aR)-6-[(4-carboxyphenyl)methyl]-decahydroisoquinoline-3-carboxylic acid

C18H23NO4 (317.1626998)


   
   

4-Nitroestradiol

4-Nitroestra-1,3,5(10)-triene-3,17beta-diol

C18H23NO4 (317.1626998)


   

2-Nitroestradiol

2-Nitroestra-1,3,5(10)-triene-3,17beta-diol; 2-Nitroestradiol

C18H23NO4 (317.1626998)


   

Cocaethylene

Ethyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C18H23NO4 (317.1626998)


Cocaethylene is a recreational drug with stimulant, euphoriant, anorectic, sympathomimetic and local anesthetic properties. Three monoamine neurotransmitters known as serotonin (5-HT), norepinephrine (NE), and dopamine (DA) play an important role in cocaethylenes action. Cocaethylene increases the level of serotonergic, noradrenergic, and dopaminergic neurotransmission by inhibiting the action of the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT) which makes cocaethylene a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).[Note 1]; Normally cocaines metabolism produces two major and biologically inactive metabolites, benzoylecogonine and ecgonine methyl ester. Carboxylesterase is an important part of cocaines metabolism because it acts as the catalyst for the hydrolysis of cocaine which produces the inactive metabolites. If ethanol is present during the metabolism of cocaine, a portion of the cocaine undergoes transesterification with ethanol, instead of undergoing hydrolysis with water, which results in cocaethylene.

   

Pandamarilactonine A

3-methyl-5-(1-{4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}pyrrolidin-2-yl)-2,5-dihydrofuran-2-one

C18H23NO4 (317.1626998)


Pandamarilactonine D is an alkaloid from Pandanus amaryllifolius. Pandamarilactonine D is a food flavouring. Alkaloid from Pandanus amaryllifolius. Food flavouring

   

Leucyl-Tryptophan

2-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-3-(1H-indol-3-yl)propanoic acid

C17H23N3O3 (317.1739328)


Leucyl-Tryptophan is a dipeptide composed of leucine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Pandamarilactone 1

3-methyl-6-{4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-1-oxa-6-azaspiro[4.5]dec-3-en-2-one

C18H23NO4 (317.1626998)


Pandamarilactone 1 is an alkaloid from leaves of Pandanus amaryllifolius. Pandamarilactone 1 is a food flavouring. Alkaloid from leaves of Pandanus amaryllifolius. Food flavouring

   

Pandanamine

(5Z)-3-methyl-5-[4-({4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}amino)butylidene]-2,5-dihydrofuran-2-one

C18H23NO4 (317.1626998)


Pandanamine is a food flavouring. Pandanamine is an alkaloid from Pandanus amaryllifoliu Food flavouring. Alkaloid from Pandanus amaryllifolius

   

Tryptophyl-Isoleucine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-methylpentanoate

C17H23N3O3 (317.1739328)


Tryptophyl-Isoleucine is a dipeptide composed of tryptophan and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Isoleucyl-Tryptophan

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-(1H-indol-3-yl)propanoate

C17H23N3O3 (317.1739328)


Isoleucyl-Tryptophan is a dipeptide composed of isoleucine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Arbutamine

4-[(1R)-1-hydroxy-2-{[4-(4-hydroxyphenyl)butyl]amino}ethyl]benzene-1,2-diol

C18H23NO4 (317.1626998)


Arbutamine, administered through a closed-loop, computer-controlled drug-delivery system, is indicated to elicit acute cardiovascular responses, similar to those produced by exercise, in order to aid in diagnosing the presence or absence of coronary artery disease in patients who cannot exercise adequately. C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Hydroxyprolyl-Tryptophan

2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}-3-(1H-indol-3-yl)propanoate

C16H19N3O4 (317.1375494)


Hydroxyprolyl-Tryptophan is a dipeptide composed of hydroxyproline and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tryptophylhydroxyproline

(2S,4R)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C16H19N3O4 (317.1375494)


​Tryptophylhydroxyproline is a dipeptide composed of tryptophan and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tryptophyl-Leucine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-methylpentanoic acid

C17H23N3O3 (317.1739328)


Tryptophyl-Leucine is a dipeptide composed of tryptophan and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

N-(1-Deoxy-1-fructosyl)histidine

(2S)-3-(1H-imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)propanoic acid

C12H19N3O7 (317.1222944)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)histidine is classified as a Natural Food Constituent (code WA) in the DFC.

   

alpha-oxycodol

(1S,13R,14S,17S)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C18H23NO4 (317.1626998)


alpha-oxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

beta-oxycodol

(1S,13R,14R,17S)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C18H23NO4 (317.1626998)


beta-oxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

N2-Monodes-methylnizatidine

[(E)-1-(methylamino)-2-nitroethenyl]({2-[({2-[(methylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl})amine

C11H19N5O2S2 (317.0980114)


N2-Monodes-methylnizatidine is a metabolite of nizatidine. Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly and is marketed under the brand names Tazac and Axid. (Wikipedia)

   

2-[5-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxy-2-pyrrolylidene]indole

2-((2Z)-2-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole methanesulfonate (1:1)

C20H19N3O (317.15280440000004)


   

Denopamine

4-(2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl)phenol

C18H23NO4 (317.1626998)


   

Puquitinib

N6-cyclopropyl-N2-(quinolin-6-yl)-7H-purine-2,6-diamine

C17H15N7 (317.138887)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Triticonazole

(1Rs)-(e)-5-((4-Chlorophenyl)methylene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol

C17H20ClN3O (317.12948200000005)


   

N-2-Mdmn

Methyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}-1,3-thiazol-2-yl)methyl]amine

C11H19N5O2S2 (317.0980114)


   
   
   
   

N-Methylpreskimmianine

N-Methylpreskimmianine

C18H23NO4 (317.1626998)


   
   
   
   
   
   
   
   
   
   

6alpha-Hydroxypowelline

6alpha-Hydroxypowelline

C17H19NO5 (317.1263164)


   
   
   
   
   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6 (317.1025082)


   

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1-methylpyrrole-2-carboxamide

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1-methylpyrrole-2-carboxamide

C14H19N7O2 (317.16001539999996)


   

6-Hydroxy-3-ketostauranthine

6-Hydroxy-3-ketostauranthine

C16H15NO6 (317.089933)


   
   

3-O-demethyltazettine

(+)-3-O-Demethyltazettine

C17H19NO5 (317.1263164)


   

O-Methylacutifolin

(-)-O-Methylacutifolin

C18H23NO4 (317.1626998)


   
   
   
   

2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile

2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile

C14H15N5O2S (317.094641)


   

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

C15H15N3O5 (317.101166)


   

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

C19H15N3O2 (317.116421)


   

Tetradecyl sodium sulfate

Tetradecyl sodium sulfate

C14H30NaO4S+ (317.17624)


   
   

8-(3-Methyl-2,5-dihydro-2-oxofuran-5-yl)-3-methyl-2,3,5,6,7,9a-hexahydrospiro[1H-pyrrolo[1,2-a]azepine-9(8H),5(2H)-furan]-2-one

8-(3-Methyl-2,5-dihydro-2-oxofuran-5-yl)-3-methyl-2,3,5,6,7,9a-hexahydrospiro[1H-pyrrolo[1,2-a]azepine-9(8H),5(2H)-furan]-2-one

C18H23NO4 (317.1626998)


   
   
   

(-)-2-oxy-indolactam V

(-)-2-oxy-indolactam V

C17H23N3O3 (317.1739328)


   
   
   
   

(-)-7,11b-dimethoxy-3,3-dimethyl-(4ar,11bc)-2,3,4a,5,6,11b-hexahydro-1H-furo[2,3-b]pyrano[2,3-h]quinoline|Anhydroperforin|anhydroperforine

(-)-7,11b-dimethoxy-3,3-dimethyl-(4ar,11bc)-2,3,4a,5,6,11b-hexahydro-1H-furo[2,3-b]pyrano[2,3-h]quinoline|Anhydroperforin|anhydroperforine

C18H23NO4 (317.1626998)


   
   

methyl 4-Amino-6-[(1R,2S,4aR,8aR)-1,2,4a,5,6,7, 8,8a-octahydro-2-methylnaphthalen-1-yl]-2-oxo-2H-pyran-3-carboxylate|solanapyrone N

methyl 4-Amino-6-[(1R,2S,4aR,8aR)-1,2,4a,5,6,7, 8,8a-octahydro-2-methylnaphthalen-1-yl]-2-oxo-2H-pyran-3-carboxylate|solanapyrone N

C18H23NO4 (317.1626998)


   

(6R)-3α-phenylacetoxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-phenylacetoxytropane|Tropane 3alpha,6beta-diol 3-phenylacetate 6-acetate|tropane-3alpha,6beta-diol 3-phenylacetate 6-acetate

(6R)-3α-phenylacetoxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-phenylacetoxytropane|Tropane 3alpha,6beta-diol 3-phenylacetate 6-acetate|tropane-3alpha,6beta-diol 3-phenylacetate 6-acetate

C18H23NO4 (317.1626998)


   
   

8-hydroxylycorin-7-one

8-hydroxylycorin-7-one

C16H15NO6 (317.089933)


   
   

7-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxyfuro[2,3-b]quinoline

7-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxyfuro[2,3-b]quinoline

C17H19NO5 (317.1263164)


   
   
   
   

2-Methoxyruteacaprine

2-Methoxyruteacaprine

C19H15N3O2 (317.116421)


   
   
   

9,10-dimethoxy-1-methyl-6,7-seco-lycoran-4(12)-en-7-al

9,10-dimethoxy-1-methyl-6,7-seco-lycoran-4(12)-en-7-al

C18H23NO4 (317.1626998)


   

4,6,8-trimethoxy-1-methyl-3-(3-methyl-but-2-enyl)-1H-quinolin-2-one|4,6,8-trimethoxy-N-methyl-3-(3-methylbut-2-enyl)-2-quinolone

4,6,8-trimethoxy-1-methyl-3-(3-methyl-but-2-enyl)-1H-quinolin-2-one|4,6,8-trimethoxy-N-methyl-3-(3-methylbut-2-enyl)-2-quinolone

C18H23NO4 (317.1626998)


   
   

9(10H)-Acridinone, 1,4,5-trihydroxy-3,6-dimethoxy-10-methyl-

9(10H)-Acridinone, 1,4,5-trihydroxy-3,6-dimethoxy-10-methyl-

C16H15NO6 (317.089933)


   

3-acetoxy-6-phenylacetoxytropane

3-acetoxy-6-phenylacetoxytropane

C18H23NO4 (317.1626998)


   
   

N-(3,4,5-Trimethoxy-cinnamoyl)-Delta5-2-oxo-tetrahydro-pyridin; Piperlongumin|N-(3,4,5-Trimethoxy-cinnamoyl)-Delta5-2-oxo-tetrahydro-pyridin; Piplartin; Piperlongumin

N-(3,4,5-Trimethoxy-cinnamoyl)-Delta5-2-oxo-tetrahydro-pyridin; Piperlongumin|N-(3,4,5-Trimethoxy-cinnamoyl)-Delta5-2-oxo-tetrahydro-pyridin; Piplartin; Piperlongumin

C17H19NO5 (317.1263164)


   

9-O-demethyl-7-O-methyllycorenine

9-O-demethyl-7-O-methyllycorenine

C18H23NO4 (317.1626998)


   

9,10-methanediyldioxy-2beta-methoxy-galanth-3(12)-ene-1alpha,4xi-diol|Ungminorin

9,10-methanediyldioxy-2beta-methoxy-galanth-3(12)-ene-1alpha,4xi-diol|Ungminorin

C17H19NO5 (317.1263164)


   

dihydroferuloyltyramine

dihydroferuloyltyramine

C18H23NO4 (317.1626998)


   
   

(S)-Cyclo(arginyldehydrotyrosyl)|cyclo-(L-Arg-dehydrotyrosine)

(S)-Cyclo(arginyldehydrotyrosyl)|cyclo-(L-Arg-dehydrotyrosine)

C15H19N5O3 (317.14878239999996)


   

1, 3, 5-trihydroxy-2, 4-dimethoxy-10-methyl-10H-acridin-9-one|citruscridone

1, 3, 5-trihydroxy-2, 4-dimethoxy-10-methyl-10H-acridin-9-one|citruscridone

C16H15NO6 (317.089933)


   

2,3-dimethoxy-1,4,5-trihydroxy-10-methylacridone

2,3-dimethoxy-1,4,5-trihydroxy-10-methylacridone

C16H15NO6 (317.089933)


   
   

methyl 2-[2-formyl-5-(methoxymethyl)-1H-pyrrol-1-yl]-3-(4-hydroxyphenyl)propanoate

methyl 2-[2-formyl-5-(methoxymethyl)-1H-pyrrol-1-yl]-3-(4-hydroxyphenyl)propanoate

C17H19NO5 (317.1263164)


   
   

nortropane-3alpha,7beta-diol 7-benzoate 3-(2-methylpropanoate)

nortropane-3alpha,7beta-diol 7-benzoate 3-(2-methylpropanoate)

C18H23NO4 (317.1626998)


   

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

C13H19NO8 (317.1110614)


   

Powelline, 6-hydroxy-

Powelline, 6-hydroxy-

C17H19NO5 (317.1263164)


   

2,3-Dimethoxy-10-methyl-1,5,6-trihydroxyacridin-9(10H)-one

2,3-Dimethoxy-10-methyl-1,5,6-trihydroxyacridin-9(10H)-one

C16H15NO6 (317.089933)


   
   
   

(R)-N-(2-phenethyl)-2-(1-acetamidoethyl)thiazole-4-carboxamide|(R)-neobacillamide A|2-[(1R)-1-(acetylamino)ethyl]-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide|Neobacillamide A

(R)-N-(2-phenethyl)-2-(1-acetamidoethyl)thiazole-4-carboxamide|(R)-neobacillamide A|2-[(1R)-1-(acetylamino)ethyl]-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide|Neobacillamide A

C16H19N3O2S (317.1197914)


   
   

7-(2-hydroxy-3-methyl-but-3-enyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Ptelefolidin|Ptelefolidine

7-(2-hydroxy-3-methyl-but-3-enyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Ptelefolidin|Ptelefolidine

C17H19NO5 (317.1263164)


   

3alpha-Tropanyl 3-hydroxy-4-methoxycinnamate

3alpha-Tropanyl 3-hydroxy-4-methoxycinnamate

C18H23NO4 (317.1626998)


   

4,5-Dihydro-2-methoxy-piperin|4,5-Dihydro-Wisanine|4,5-Dihydrowisanin|Deltaalpha,beta-Dihydrowasanin|Deltaalphabeta-dihydrowisanine|N-piperidyl-5-(2-methoxy-4,5-methylenedioxyphenyl)-2-pentenamide

4,5-Dihydro-2-methoxy-piperin|4,5-Dihydro-Wisanine|4,5-Dihydrowisanin|Deltaalpha,beta-Dihydrowasanin|Deltaalphabeta-dihydrowisanine|N-piperidyl-5-(2-methoxy-4,5-methylenedioxyphenyl)-2-pentenamide

C18H23NO4 (317.1626998)


   

6-methoxy-9-methyl-7-(3-methyl-2-oxo-butyl)-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|isoorixinone|Lunidonin|Lunidonine|N-demethyllunidonine

6-methoxy-9-methyl-7-(3-methyl-2-oxo-butyl)-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|isoorixinone|Lunidonin|Lunidonine|N-demethyllunidonine

C17H19NO5 (317.1263164)


   

Methoxydianthramide M

Methoxydianthramide M

C16H15NO6 (317.089933)


   
   
   
   
   
   
   

1-NAPHTHYL PP1

1-(tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C19H19N5 (317.1640374)


   
   

glycylasparagyllysine

glycylasparagyllysine

C12H23N5O5 (317.1699108)


   
   
   
   
   
   

asparagylglycyllysine

asparagylglycyllysine

C12H23N5O5 (317.1699108)


   
   
   
   
   
   

1,3,6-trihydroxy-4,5-dimethoxy-10-methylacridin-9-one

NCGC00385951-01!1,3,6-trihydroxy-4,5-dimethoxy-10-methylacridin-9-one

C16H15NO6 (317.089933)


   

14-Formyldihydrorutaecarpine

14-Formyldihydrorutaecarpine

C19H15N3O2 (317.116421)


   

C18H23NO4_1H-Pyrrolo[3,2,1-de]phenanthridin-1-ol, 2,4,5,7,11b,11c-hexahydro-2,9,10-trimethoxy-, (1S,2S,11bS,11cS)

NCGC00384634-01_C18H23NO4_1H-Pyrrolo[3,2,1-de]phenanthridin-1-ol, 2,4,5,7,11b,11c-hexahydro-2,9,10-trimethoxy-, (1S,2S,11bS,11cS)-

C18H23NO4 (317.1626998)


   

C18H23NO4_Furo[2,3-b]quinolin-7-ol, 5,6,7,8-tetrahydro-4,8-dimethoxy-8-(3-methyl-2-buten-1-yl)

NCGC00385071-01_C18H23NO4_Furo[2,3-b]quinolin-7-ol, 5,6,7,8-tetrahydro-4,8-dimethoxy-8-(3-methyl-2-buten-1-yl)-

C18H23NO4 (317.1626998)


   

Cocaethylene

Cocaethylene

C18H23NO4 (317.1626998)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Piplartine

Piperlongumine

C17H19NO5 (317.1263164)


Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3]. Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3]. Piperlongumine is a alkaloid[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway. Piperlongumin could be used in the study of migrasome[2][3].

   
   

Piperlongumine

Piperlongumine

C17H19NO5 (317.1263164)


Annotation level-1

   

Dubinine

(2S)-2-hydroxy-2-(4-methoxy-2,3-dihydrofuro[2,3-b]quinolin-2-yl)propyl acetate

C17H19NO5 (317.1263164)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

   

Tsitsikammamine A N-oxime / B

Tsitsikammamine A N-oxime / B

C19H15N3O2 (317.116421)


   

Oxyphenisatin

Oxyphenisatine

C20H15NO3 (317.105188)


CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3927; ORIGINAL_PRECURSOR_SCAN_NO 3925 A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3937; ORIGINAL_PRECURSOR_SCAN_NO 3935 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3903; ORIGINAL_PRECURSOR_SCAN_NO 3901 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3930; ORIGINAL_PRECURSOR_SCAN_NO 3928 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3916; ORIGINAL_PRECURSOR_SCAN_NO 3914 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3917; ORIGINAL_PRECURSOR_SCAN_NO 3916 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7982; ORIGINAL_PRECURSOR_SCAN_NO 7981 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7987; ORIGINAL_PRECURSOR_SCAN_NO 7982 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8022; ORIGINAL_PRECURSOR_SCAN_NO 8020 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8036; ORIGINAL_PRECURSOR_SCAN_NO 8034 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8042; ORIGINAL_PRECURSOR_SCAN_NO 8039

   

3,N4-Benzoquinone-deoxycytodine

3,N4-Benzoquinone-deoxycytodine

C15H15N3O5 (317.101166)


   

Ala Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C11H19N5O6 (317.1335274)


   

Ala Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C11H19N5O6 (317.1335274)


   

Ala Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C11H19N5O6 (317.1335274)


   

Gly Ala Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-3-carbamoylpropanoic acid

C11H19N5O6 (317.1335274)


   

Gly Ala Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]acetic acid

C11H19N5O6 (317.1335274)


   

Gly Gly Ala Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-3-carbamoylpropanoic acid

C11H19N5O6 (317.1335274)


   

Gly Gly Gly Lys

(2S)-6-amino-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}hexanoic acid

C12H23N5O5 (317.1699108)


   

Gly Gly Gly Gln

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-4-carbamoylbutanoic acid

C11H19N5O6 (317.1335274)


   

Gly Gly Lys Gly

2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]acetic acid

C12H23N5O5 (317.1699108)


   

Gly Gly Asn Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]propanoic acid

C11H19N5O6 (317.1335274)


   

Gly Gly Gln Gly

2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]acetic acid

C11H19N5O6 (317.1335274)


   

Gly Lys Gly Gly

2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}acetic acid

C12H23N5O5 (317.1699108)


   

Gly Asn Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]acetic acid

C11H19N5O6 (317.1335274)


   

Gly Asn Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}propanoic acid

C11H19N5O6 (317.1335274)


   

Gly Gln Gly Gly

2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}acetic acid

C11H19N5O6 (317.1335274)


   
   
   
   
   
   

Lys Gly Gly Gly

2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)acetic acid

C12H23N5O5 (317.1699108)


   

1,2-Benzenediol, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-, (3S-trans)-

1,2-Benzenediol, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-, (3S-trans)-

C18H20FNO3 (317.1427142)


   
   
   
   

Asn Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}acetic acid

C11H19N5O6 (317.1335274)


   
   

Asn Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]acetic acid

C11H19N5O6 (317.1335274)


   

Asn Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)propanoic acid

C11H19N5O6 (317.1335274)


   
   
   
   
   

Gln Gly Gly Gly

2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)acetic acid

C11H19N5O6 (317.1335274)


   
   
   
   
   
   
   
   
   
   
   
   

3-O-Methylrimiterol sulfate

3-O-Methylrimiterol sulfate

C13H19NO6S (317.0933034)


   
   
   
   
   
   

Arbutamine

4-[(1R)-1-hydroxy-2-{[4-(4-hydroxyphenyl)butyl]amino}ethyl]benzene-1,2-diol

C18H23NO4 (317.1626998)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Hpro-TRP

1-[2-amino-3-(1H-indol-3-yl)propanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C16H19N3O4 (317.1375494)


   

Ile-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C17H23N3O3 (317.1739328)


A dipeptide formed from L-isoleucine and L-tryptophan residues.

   

Leu-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C17H23N3O3 (317.1739328)


A dipeptide formed from L-leucine and L-tryptophan residues.

   

TRP-HPro

2-[(4-hydroxypyrrolidin-2-yl)formamido]-3-(1H-indol-3-yl)propanoic acid

C16H19N3O4 (317.1375494)


   

TRP-Ile

2-(2-amino-3-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid

C17H23N3O3 (317.1739328)


   

TRP-Leu

2-(2-amino-4-methylpentanamido)-3-(1H-indol-3-yl)propanoic acid

C17H23N3O3 (317.1739328)


A dipeptide formed from L-tryptophan and L-leucine residues.

   

Pandamarilactonine A

3-methyl-5-(1-{4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}pyrrolidin-2-yl)-2,5-dihydrofuran-2-one

C18H23NO4 (317.1626998)


   

Pandanamine

(5Z)-3-methyl-5-[4-({4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}amino)butylidene]-2,5-dihydrofuran-2-one

C18H23NO4 (317.1626998)


   

Pandamarilactone 1

3-methyl-6-{4-[(2Z)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-1-oxa-6-azaspiro[4.5]dec-3-en-2-one

C18H23NO4 (317.1626998)


   

Homocaine

ethyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

C18H23NO4 (317.1626998)


   

Phthalazinone pyrazole

Phthalazinone pyrazole

C18H15N5O (317.127654)


   

1-NA-PP1

1-NAPHTHYL PP1

C19H19N5 (317.1640374)


   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025082)


   
   

5,6-Dihydro-8,9-dimethoxypyrrolo[2,1-a]isoquinoline-2,3-dicarboxylic acid

5,6-Dihydro-8,9-dimethoxypyrrolo[2,1-a]isoquinoline-2,3-dicarboxylic acid

C16H15NO6 (317.089933)


   
   

diethyl 6-ethoxyquinoline-2,3-dicarboxylate

diethyl 6-ethoxyquinoline-2,3-dicarboxylate

C17H19NO5 (317.1263164)


   

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.10274300000003)


   

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

C13H19NO8 (317.1110614)


   

4-CHLORO-5-METHYL-N-(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)PYRIMIDIN-2-AMINE

4-CHLORO-5-METHYL-N-(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)PYRIMIDIN-2-AMINE

C16H20ClN5 (317.140715)


   

6-Benzyl-2-phenyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one

6-Benzyl-2-phenyl-5,6,7,8-tetrahydro-3H-pyrido[4,3-d]pyrimidin-4-one

C20H19N3O (317.15280440000004)


   
   

5-[(3,5-dimethoxybenzoyl)amino]-2-hydroxybenzoic acid

5-[(3,5-dimethoxybenzoyl)amino]-2-hydroxybenzoic acid

C16H15NO6 (317.089933)


   

Synephrine tartrate

Synephrine tartrate

C13H19NO8 (317.1110614)


   

methyl 4-{[(benzyloxy)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate

methyl 4-{[(benzyloxy)carbonyl]amino}bicyclo[2.2.2]octane-1-carboxylate

C18H23NO4 (317.1626998)


   

6-Ethoxy-5-(trifluoromethyl)pyridine-3-boronic acid pinacol ester

6-Ethoxy-5-(trifluoromethyl)pyridine-3-boronic acid pinacol ester

C14H19BF3NO3 (317.1410010000001)


   

sodium N-(2-carboxyethyl)-N-(2-ethylhexyl)-beta-alaninate

sodium N-(2-carboxyethyl)-N-(2-ethylhexyl)-beta-alaninate

C14H25NNa2O4 (317.157889)


   

Metaraminol bitartrate

Metaraminol bitartrate

C13H19NO8 (317.1110614)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Imipenem

Imipenem hydrate

C12H19N3O5S (317.10453640000003)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

C13H14F3N3O3 (317.09872100000007)


   

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.10274300000003)


   

6-(DIMETHOXYMETHYL)-3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE

6-(DIMETHOXYMETHYL)-3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE

C16H24BNO3Si (317.1618424)


   

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

Diphenylpyraline hydrochloride

Diphenylpyraline (hydrochloride)

C19H24ClNO (317.1546324)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline hydrochloride is a potent histamine H1?receptor antagonist. Diphenylpyraline hydrochloride acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline hydrochloride can be used for the relief of allergic conditions including rhinitis and hay fever, and in pruritic skin disorders in vivo.[1]

   

tert-butyl 3-(4-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

tert-butyl 3-(4-fluorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

C17H20FN3O2 (317.1539472)


   

2-TERT-BUTYL-6-(5-CHLORO-1,3-DIHYDRO-BENZOTRIAZOL-2-YL)-4-METHYL-PHENOL

2-TERT-BUTYL-6-(5-CHLORO-1,3-DIHYDRO-BENZOTRIAZOL-2-YL)-4-METHYL-PHENOL

C17H20ClN3O (317.12948200000005)


   

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

C18H20ClNO2 (317.11824900000005)


   

Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate

Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate

C15H21Cl2NO2 (317.0949266)


   

2-dodecylsulfanylcarbothioylsulfanylacetonitrile

2-dodecylsulfanylcarbothioylsulfanylacetonitrile

C15H27NS3 (317.1305542)


   

3-(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)prop-2-yn-1-ol

3-(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)prop-2-yn-1-ol

C17H23NO3Si (317.1447128)


   

N-Dipropyldopamine hydrobromide

N-Dipropyldopamine hydrobromide

C14H24BrNO2 (317.0990304)


   
   

(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)(THIAZOL-2-YL)METHANOL

(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)(THIAZOL-2-YL)METHANOL

C16H20BNO3S (317.1256880000001)


   

1-Benzyl 3-methyl 3-allyl-1,3-piperidinedicarboxylate

1-Benzyl 3-methyl 3-allyl-1,3-piperidinedicarboxylate

C18H23NO4 (317.1626998)


   

Phenylephrine tartrate

(-)-Phenylephrine hydrogentartrate

C13H19NO8 (317.1110614)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1-benzhydrylazetidin-3-yl Methanesulfonate

1-benzhydrylazetidin-3-yl Methanesulfonate

C17H19NO3S (317.1085584)


   

Benzoic acid, 4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-

Benzoic acid, 4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-

C16H15NO6 (317.089933)


   

N-Methyl-2,2-iminodi(8-quinolinol)

N-Methyl-2,2-iminodi(8-quinolinol)

C19H15N3O2 (317.116421)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(4-fluorophenyl)-1,5-dihydro-3-hydroxy-, (5R)-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(4-fluorophenyl)-1,5-dihydro-3-hydroxy-, (5R)-

C18H20FNO3 (317.1427142)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(3-fluorophenyl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(3-fluorophenyl)-1,5-dihydro-3-hydroxy-

C18H20FNO3 (317.1427142)


   

Phentolamine hydrochloride

Phentolamine hydrochloride

C17H20ClN3O (317.12948200000005)


Phentolamine hydrochloride is an orally active adrenergic α receptor-blocking agent[1].

   

dibenzyl diethylphosphoramidite

dibenzyl diethylphosphoramidite

C18H24NO2P (317.1544574)


   

RS 127445

RS 127445

C17H17ClFN3 (317.1094964)


RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites[1].

   

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

C17H16FNO4 (317.10633079999997)


   

Pridopidine hydrochloride

4-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE, HYDROCHLORIDE

C15H24ClNO2S (317.1216194)


C78272 - Agent Affecting Nervous System

   

(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal

(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal

C21H16FNO (317.1215858)


   

tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

C13H20ClN3O2S (317.096469)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]

C17H20FN3O2 (317.1539472)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

C17H20FN3O2 (317.1539472)


   

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(2-fluorophenyl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-5-cyclohexyl-1-(2-fluorophenyl)-1,5-dihydro-3-hydroxy-

C18H20FNO3 (317.1427142)


   

DI-TERT-BUTYL 1H-INDOLE-1,5-DICARBOXYLATE

DI-TERT-BUTYL 1H-INDOLE-1,5-DICARBOXYLATE

C18H23NO4 (317.1626998)


   

3-(4-Chlorophenyl)-3-(2-phenylacetamido)propanoic acid

3-(4-Chlorophenyl)-3-(2-phenylacetamido)propanoic acid

C17H16ClNO3 (317.0818656)


   

Sodium hydroxytetradecane sulfonate

Sodium hydroxytetradecane sulfonate

C14H30NaO4S (317.17624)


   

2-(3,5-DIMETHYL-BIPHENYL-3-YLAMINO)-BENZOIC ACID

2-(3,5-DIMETHYL-BIPHENYL-3-YLAMINO)-BENZOIC ACID

C21H19NO2 (317.14157140000003)


   
   
   

(S)-Decarboxyl ofloxacin

(S)-Decarboxyl ofloxacin

C17H20FN3O2 (317.1539472)


   

1,3-DI-BOC-2-(CARBOXYMETHYL)GUANIDINE

1,3-DI-BOC-2-(CARBOXYMETHYL)GUANIDINE

C13H23N3O6 (317.15867779999996)


   

Bis(2,4-dimethoxybenzyl)amine

Bis(2,4-dimethoxybenzyl)amine

C18H23NO4 (317.1626998)


   

[4-(Dibenzylamino)phenyl]boronic acid

[4-(Dibenzylamino)phenyl]boronic acid

C20H20BNO2 (317.158701)


   

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

C20H15NO3 (317.105188)


   

Methyl 4-benzyloxy-5-methoxy-2-nitrobenzoate

Methyl 4-benzyloxy-5-methoxy-2-nitrobenzoate

C16H15NO6 (317.089933)


   

3-(2,5-dimethylphenyl)-3-hydroxy-8-methoxy-1-azaspiro[4.5]decane-2,4-dione

3-(2,5-dimethylphenyl)-3-hydroxy-8-methoxy-1-azaspiro[4.5]decane-2,4-dione

C18H23NO4 (317.1626998)


   

tert-butyl N-[1-(2-cyanoethylamino)-1-oxo-3-phenylpropan-2-yl]carbamate

tert-butyl N-[1-(2-cyanoethylamino)-1-oxo-3-phenylpropan-2-yl]carbamate

C17H23N3O3 (317.1739328)


   

[4-[bis(4-methylphenyl)amino]phenyl]Boronic acid

[4-[bis(4-methylphenyl)amino]phenyl]Boronic acid

C20H20BNO2 (317.158701)


   

ethyl 2-piperazine-4-phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-phenyl thiazole-5-carboxylate

C16H19N3O2S (317.1197914)


   

ethyl 2-(3-n-phthalimidopropyl)acetoacetate

ethyl 2-(3-n-phthalimidopropyl)acetoacetate

C17H19NO5 (317.1263164)


   

(7-amino-2-methylphenoxazin-3-ylidene)-diethylazanium,chloride

(7-amino-2-methylphenoxazin-3-ylidene)-diethylazanium,chloride

C17H20ClN3O (317.12948200000005)


   

tri-n-butylcyanotin

tri-n-butylcyanotin

C13H27NSn (317.1165372)


   
   
   
   

ETHYL 3-((4-ACETAMIDO-3-ETHOXYPHENYL)AMINO)-2-CYANOACRYLATE

ETHYL 3-((4-ACETAMIDO-3-ETHOXYPHENYL)AMINO)-2-CYANOACRYLATE

C16H19N3O4 (317.1375494)


   

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

C13H21Cl2N5 (317.1173926)


   

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C16H16FN3O3 (317.11756379999997)


   

N-Benzyl-2-methoxy-N-phenylbenzamide

N-Benzyl-2-methoxy-N-phenylbenzamide

C21H19NO2 (317.14157140000003)


   

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

C14H17F2NO5 (317.1074736)


   
   

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C14H19BF3NO3 (317.1410010000001)


   

tert-Butyl 4-oxospiro[chroman-2,4-piperidine]-1-carboxylate

tert-Butyl 4-oxospiro[chroman-2,4-piperidine]-1-carboxylate

C18H23NO4 (317.1626998)


   

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

C13H15BF3NO4 (317.1046176)


   

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

C12H15BF3N3O3 (317.11585060000004)


   

4-(2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H23N3O3 (317.1739328)


   

N-(2-HYDROXY-2,2-DIPHENYLETHYL)BENZENECARBOXAMIDE

N-(2-HYDROXY-2,2-DIPHENYLETHYL)BENZENECARBOXAMIDE

C21H19NO2 (317.14157140000003)


   

Methyl 5-(benzyloxy)-4-methoxy-2-nitrobenzoate

Methyl 5-(benzyloxy)-4-methoxy-2-nitrobenzoate

C16H15NO6 (317.089933)


   

disodium,2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate,hydrate

disodium,2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate,hydrate

C17H19NO5 (317.1263164)


   

Iron(III) 2-ethylhexano-isopropoxide, 10 w/v in isopropanol

Iron(III) 2-ethylhexano-isopropoxide, 10 w/v in isopropanol

C14H29FeO4 (317.1415124)


   

ETHYL 3-(3-(2-ETHOXY-2-OXOETHYL)-1-METHYL-1H-INDOL-2-YL)PROPANOATE

ETHYL 3-(3-(2-ETHOXY-2-OXOETHYL)-1-METHYL-1H-INDOL-2-YL)PROPANOATE

C18H23NO4 (317.1626998)


   
   

Denopamine

Denopamine

C18H23NO4 (317.1626998)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Denopamine ((R)-(-)-Denopamine) is an orally active, selective β1-adrenergic agonist. Denopamine prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-α production in the heart. Cardiovascular effects[1].

   

N-Benzyl-4-(benzylamino)picolinamide

N-Benzyl-4-(benzylamino)picolinamide

C20H19N3O (317.15280440000004)


   

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

C18H14F3NO (317.10274300000003)


   

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride

C16H16ClN3O2 (317.09309859999996)


   

obatoclax

(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

C20H19N3O (317.15280440000004)


C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C192025 - Bcl-2 Family Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C159200 - BCL-2 Inhibitor D004791 - Enzyme Inhibitors

   

AE-37 hydrochloride

AE-37 hydrochloride

C19H24ClNO (317.1546324)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

N-[(3S)-1-Chloro-5-methyl-2-oxohexan-3-yl]-4-methylbenzene-1-sulfonamide

N-[(3S)-1-Chloro-5-methyl-2-oxohexan-3-yl]-4-methylbenzene-1-sulfonamide

C14H20ClNO3S (317.085236)


   

3-methyl-5-[4-[2-(4-methyl-5-oxo-2H-furan-2-yl)pyrrolidin-1-yl]butylidene]furan-2-one

(5Z)-3-methyl-5-[4-[2-(4-methyl-5-oxo-2H-furan-2-yl)pyrrolidin-1-yl]butylidene]furan-2-one

C18H23NO4 (317.1626998)


   

Isoleucyl-Tryptophan

Isoleucyl-Tryptophan

C17H23N3O3 (317.1739328)


BNC210 (H-Ile-Trp-OH) is an orally active α7 nAChR negative alteration modulator (NAM) with no apparent side effects. BNC210 exhibits acute anxiolytic activity in rodent models of anxiety. BNC210 can be used in studies of generalised anxiety disorders[1].

   

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

C18H20ClNO2 (317.11824900000005)


SKF83959 is a potent and selective dopamine D1-like receptor partial agonist. SKF83959 Ki values for rat D1, D5, D2 and D3 receptors are 1.18, 7.56, 920 and 399 nM, respectively. SKF83959 is a potent allosteric modulator of sigma (σ)-1 receptor. SKF83959 belongs to benzazepine family and has improvements on cognitive dysfunction. SKF83959 can be used for the research of Alzheimer's disease and depression[1][2][3][4].

   
   

Mecloxamine

Mecloxamine

C19H24ClNO (317.1546324)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

(3S,4aR,6S,8aR)-6-[(4-carboxyphenyl)methyl]-decahydroisoquinoline-3-carboxylic acid

(3S,4aR,6S,8aR)-6-[(4-carboxyphenyl)methyl]-decahydroisoquinoline-3-carboxylic acid

C18H23NO4 (317.1626998)


   

2-Nitroestra-1,3,5(10)-triene-3,17beta-diol

2-Nitroestra-1,3,5(10)-triene-3,17beta-diol

C18H23NO4 (317.1626998)


   

O-Benzoyl-N,N-dibenzylhydroxylamine

O-Benzoyl-N,N-dibenzylhydroxylamine

C21H19NO2 (317.14157140000003)


   

N-biphenyl-2-yl-N-(4,6-dimethylpyrimidin-2-yl)guanidine

N-biphenyl-2-yl-N-(4,6-dimethylpyrimidin-2-yl)guanidine

C19H19N5 (317.1640374)


   

4-Nitroestra-1,3,5(10)-triene-3,17beta-diol

4-Nitroestra-1,3,5(10)-triene-3,17beta-diol

C18H23NO4 (317.1626998)


   
   

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

C17H19NO3S (317.1085584)


   

4-Amino-2-(phenacylthio)-5-pyrimidinecarboxylic acid ethyl ester

4-Amino-2-(phenacylthio)-5-pyrimidinecarboxylic acid ethyl ester

C15H15N3O3S (317.083408)


   

1-Adamantanecarboxylic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester

1-Adamantanecarboxylic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester

C18H23NO4 (317.1626998)


   

5-({[(Isopropylamino)carbonyl]oxy}ethanimidoyl)-4-methyl-2-phenyl-1,3-thiazole

5-({[(Isopropylamino)carbonyl]oxy}ethanimidoyl)-4-methyl-2-phenyl-1,3-thiazole

C16H19N3O2S (317.1197914)


   

5-Methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-5-phenylimidazolidine-2,4-dione

5-Methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-5-phenylimidazolidine-2,4-dione

C16H19N3O4 (317.1375494)


   
   
   

4,8-Dimethoxy-8-(3-methyl-but-2-enyl)-5,6,7,8-tetrahydro-furo[2,3-b]quinolin-7-ol

4,8-Dimethoxy-8-(3-methyl-but-2-enyl)-5,6,7,8-tetrahydro-furo[2,3-b]quinolin-7-ol

C18H23NO4 (317.1626998)


   

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

C15H15N3O5 (317.101166)


   

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

C20H15NO3 (317.105188)


   

4-Sulfonamide-[4-(thiomethylaminobutane)]benzamide

4-Sulfonamide-[4-(thiomethylaminobutane)]benzamide

C12H19N3O3S2 (317.0867784)


   
   

(alphaS)-alpha-(Trimethylaminio)-2-[[(R)-2-amino-3-oxo-3-hydroxypropyl]thio]-1H-imidazole-4-propanoic acid anion

(alphaS)-alpha-(Trimethylaminio)-2-[[(R)-2-amino-3-oxo-3-hydroxypropyl]thio]-1H-imidazole-4-propanoic acid anion

C12H21N4O4S+ (317.12834460000005)


   

L-methionyl-L-prolyl-L-alanine tripeptide

L-methionyl-L-prolyl-L-alanine tripeptide

C13H23N3O4S (317.1409198)


   

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

C12H19N3O5S (317.10453640000003)


   

4-[2-[2-(3,4-Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

4-[2-[2-(3,4-Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

C18H23NO4 (317.1626998)


   

Tryptophyl-hydroxyproline

Tryptophyl-hydroxyproline

C16H19N3O4 (317.1375494)


   

(2Z)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

(2Z)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole

C20H19N3O (317.15280440000004)


   

(4aS,7R,7aR,12bS)-9-methoxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

(4aS,7R,7aR,12bS)-9-methoxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

C18H23NO4 (317.1626998)


   

(4-Methylphenyl)-(10-phenothiazinyl)methanone

(4-Methylphenyl)-(10-phenothiazinyl)methanone

C20H15NOS (317.08743000000004)


   

N-(4-chlorophenyl)-3-(pyrrol-1-ylmethyl)piperidine-1-carboxamide

N-(4-chlorophenyl)-3-(pyrrol-1-ylmethyl)piperidine-1-carboxamide

C17H20ClN3O (317.12948200000005)


   

Leu-Ala-Asp

Leu-Ala-Asp

C13H23N3O6 (317.15867779999996)


A tripeptide composed of L-leucine L-alanine, and L-aspartic acid joined in sequence by peptide linkages.

   

1,2-Benzenediol, 4-(((3S,4R)-4-(4-fluorophenyl)-3-piperidinyl)methoxy)-

1,2-Benzenediol, 4-(((3S,4R)-4-(4-fluorophenyl)-3-piperidinyl)methoxy)-

C18H20FNO3 (317.1427142)


   

3,5-Diacetyl-1,4-diphenyl-1,4-dihydropyridine

3,5-Diacetyl-1,4-diphenyl-1,4-dihydropyridine

C21H19NO2 (317.14157140000003)


   

3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]propanamide

3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]propanamide

C17H19NO5 (317.1263164)


   

N-(2,3-dihydro-1H-inden-5-yl)-2-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)thio]acetamide

N-(2,3-dihydro-1H-inden-5-yl)-2-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)thio]acetamide

C15H15N3O3S (317.083408)


   

5-(3-hydroxyphenyl)-N-[2-(4-morpholinyl)ethyl]-3-isoxazolecarboxamide

5-(3-hydroxyphenyl)-N-[2-(4-morpholinyl)ethyl]-3-isoxazolecarboxamide

C16H19N3O4 (317.1375494)


   

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

C13H14F3N3O3 (317.09872100000007)


   

2-Chlorobenzyl 4-(propionylamino)benzoate

2-Chlorobenzyl 4-(propionylamino)benzoate

C17H16ClNO3 (317.0818656)


   
   
   

N-(4-nitrophenyl)-9-oxobicyclo[3.3.1]nonane-3-carbohydrazide

N-(4-nitrophenyl)-9-oxobicyclo[3.3.1]nonane-3-carbohydrazide

C16H19N3O4 (317.1375494)


   

3-[5-(4-Fluorophenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

3-[5-(4-Fluorophenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

C18H20FNO3 (317.1427142)


   

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C17H19NO3S (317.1085584)


   

N-(6-chloro-2,3-dihydro-1,4-benzodioxin-7-yl)-3-phenylpropanamide

N-(6-chloro-2,3-dihydro-1,4-benzodioxin-7-yl)-3-phenylpropanamide

C17H16ClNO3 (317.0818656)


   

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

C15H16ClN5O (317.10433159999997)


   

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

C15H16ClN5O (317.10433159999997)


   

methyl 5-[(E)-3-(2-chlorophenyl)prop-2-enoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

methyl 5-[(E)-3-(2-chlorophenyl)prop-2-enoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

C17H16ClNO3 (317.0818656)


   

methyl 5-[(E)-3-(3-chlorophenyl)prop-2-enoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

methyl 5-[(E)-3-(3-chlorophenyl)prop-2-enoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

C17H16ClNO3 (317.0818656)


   

1-(4-amino-1,2,5-oxadiazol-3-yl)-3-[(E)-[4-(diethylamino)phenyl]methylideneamino]urea

1-(4-amino-1,2,5-oxadiazol-3-yl)-3-[(E)-[4-(diethylamino)phenyl]methylideneamino]urea

C14H19N7O2 (317.16001539999996)


   

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

C15H15N3O5 (317.101166)


   

3-hydroxy-6,7-dimethyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

3-hydroxy-6,7-dimethyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

C18H23NO4 (317.1626998)


   

Nobilisitine A

Nobilisitine A

C17H19NO5 (317.1263164)


A natural product found in Clivia nobilis.

   

N-benzyl-4-[(2E)-2-benzylidenehydrazinyl]-6-methylpyrimidin-2-amine

N-benzyl-4-[(2E)-2-benzylidenehydrazinyl]-6-methylpyrimidin-2-amine

C19H19N5 (317.1640374)


   

(2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oate

(2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oate

C18H21O5- (317.1388916)


A steroid acid anion that is the conjugate base of (2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. A meta-cleavage metabolite in the estrogen degradation pathway.

   
   
   
   
   
   
   
   
   
   
   

4-Chloro-2-[[oxo-(4-propan-2-ylphenyl)methyl]amino]benzoic acid

4-Chloro-2-[[oxo-(4-propan-2-ylphenyl)methyl]amino]benzoic acid

C17H16ClNO3 (317.0818656)


   

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

C13H19NO8 (317.1110614)


   

4-Benzhydryloxy-1-methylpiperidin-1-ium;chloride

4-Benzhydryloxy-1-methylpiperidin-1-ium;chloride

C19H24ClNO (317.1546324)


   
   

(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C17H23N3O3 (317.1739328)


   

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

C15H15N3O5 (317.101166)


   

(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C17H23N3O3 (317.1739328)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

C13H12FN7O2 (317.1036464)


   
   
   

9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxononanoate

9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxononanoate

C15H25O7- (317.16002000000003)


   

(8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxononanoate

(8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxononanoate

C15H25O7- (317.16002000000003)


   

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

C15H15N3O5 (317.101166)


   

(5S)-5-((1R)-1-Amino-2-oxo-2-hydroxyethyl)uridine

(5S)-5-((1R)-1-Amino-2-oxo-2-hydroxyethyl)uridine

C11H15N3O8 (317.085911)


   

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.116421)


   

2-Butoxy-4-quinolinecarboxylic acid trimethylsilyl ester

2-Butoxy-4-quinolinecarboxylic acid trimethylsilyl ester

C17H23NO3Si (317.1447128)


   

(3S,4aS,11bS,12R)-3-methoxy-4,4a-dihydro-3H,6H-11b,5-ethano[1,3]dioxolo[4,5-j]phenanthridine-6,12-diol

(3S,4aS,11bS,12R)-3-methoxy-4,4a-dihydro-3H,6H-11b,5-ethano[1,3]dioxolo[4,5-j]phenanthridine-6,12-diol

C17H19NO5 (317.1263164)


   
   

Oxyphenisatine

Oxyphenisatine

C20H15NO3 (317.105188)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics

   
   

Ethylbenzoylecgonine

Ethylbenzoylecgonine

C18H23NO4 (317.1626998)


   
   
   

Hydroxyprolyl-Tryptophan

Hydroxyprolyl-Tryptophan

C16H19N3O4 (317.1375494)


   

N-(1-Deoxy-1-fructosyl)histidine

N-(1-Deoxy-1-fructosyl)histidine

C12H19N3O7 (317.1222944)


   

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025082)


   

pyranonigrin G

pyranonigrin G

C18H23NO4 (317.1626998)


A member of the class of pyranopyrroles with formula C18H23NO4, originally isolated from Aspergillus niger.

   
   
   

LY456236

LY456236

C16H16ClN3O2 (317.09309859999996)


LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3].